2-202513675-CTT-CT
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BS2BA1BP4
This summary comes from the ClinGen Evidence Repository: The BMPR2 c.419-38del is an intronic variant at Intron 3. The highest population minor allele frequency in gnomAD v2.1.1 (controls) is 0.1814 (2514/13856 alleles) in European (Finnish) population, which is higher than the ClinGen Pulmonary Hypertension Expert Panel threshold (>0.01) for BA1, and therefore meets this stand-alone criterion (BA1). This variant has been observed in 1160 times in homozygous state in healthy individuals (BS2). The computational splicing predictor SpliceAI gives a score of (0.00) for acceptor splice site loss suggesting that the variant has no impact on splicing (BP4). In summary, the variant is classified as benign for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: BA1, BS2, BP4 (VCEP specification version v 1.1, 1/18/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA2061113/MONDO:0015924/125
Frequency
Consequence
NM_001204.7 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMPR2 | NM_001204.7 | c.419-38del | intron_variant | ENST00000374580.10 | NP_001195.2 | |||
BMPR2 | XM_011511687.2 | c.419-38del | intron_variant | XP_011509989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMPR2 | ENST00000374580.10 | c.419-38del | intron_variant | 1 | NM_001204.7 | ENSP00000363708 | P1 | |||
BMPR2 | ENST00000374574.2 | c.419-38del | intron_variant | 2 | ENSP00000363702 |
Frequencies
GnomAD3 genomes AF: 0.125 AC: 19016AN: 151826Hom.: 1262 Cov.: 30
GnomAD3 exomes AF: 0.126 AC: 31203AN: 246956Hom.: 2207 AF XY: 0.126 AC XY: 16832AN XY: 133982
GnomAD4 exome AF: 0.128 AC: 168474AN: 1318366Hom.: 11456 Cov.: 16 AF XY: 0.128 AC XY: 84715AN XY: 663834
GnomAD4 genome AF: 0.125 AC: 19045AN: 151942Hom.: 1266 Cov.: 30 AF XY: 0.127 AC XY: 9412AN XY: 74272
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension associated with congenital heart disease Uncertain:1
Uncertain significance, criteria provided, single submitter | case-control | Wendy Chung Laboratory, Columbia University Medical Center | Jun 27, 2018 | - - |
Pulmonary arterial hypertension Benign:1
Benign, reviewed by expert panel | curation | Clingen Pulmonary Hypertension Variant Curation Expert Panel, ClinGen | May 03, 2024 | The BMPR2 c.419-38del is an intronic variant at Intron 3. The highest population minor allele frequency in gnomAD v2.1.1 (controls) is 0.1814 (2514/13856 alleles) in European (Finnish) population, which is higher than the ClinGen Pulmonary Hypertension Expert Panel threshold (>0.01) for BA1, and therefore meets this stand-alone criterion (BA1). This variant has been observed in 1160 times in homozygous state in healthy individuals (BS2). The computational splicing predictor SpliceAI gives a score of (0.00) for acceptor splice site loss suggesting that the variant has no impact on splicing (BP4). In summary, the variant is classified as benign for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: BA1, BS2, BP4 (VCEP specification version v 1.1, 1/18/2024). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 20, 2019 | This variant is associated with the following publications: (PMID: 30029678) - |
Primary pulmonary hypertension Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at